How many insider trades does FilingIQ track for AKTS?

FilingIQ tracks 352 Form 4 insider transactions for AKTS (Aktis Oncology, Inc.), covering filings from Jul 10, 2017 onwards. 1 of those were filed in the last 90 days.

Are AKTS insiders net buyers or net sellers?

Across the full Form 4 history for AKTS, 25 transactions (7%) were open-market purchases and 181 (51%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does AKTS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is AKTS in?

Aktis Oncology, Inc. (AKTS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $838.03M.

AKTS insider trading

NasdaqGS Healthcare

Aktis Oncology, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

352

Last 90 days

Buys / sells

7% / 51%

Market cap

$838.03M

About Aktis Oncology, Inc.

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD276 expressing tumors targeting prostate, lung and other solid tumors. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is based in Boston, Massachusetts.

Company website: www.aktisoncology.com

AKTS insider activity at a glance

FilingIQ has scored 352 insider transactions for AKTS since Jul 10, 2017. The most recent filing in our index is dated Apr 15, 2026.

Across the full history, 25 open-market purchases and 181 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AKTS insider trades is 60.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live AKTS trades on FilingIQ Raw filings on SEC EDGAR

Latest AKTS Form 4 filings

Shealy Jeffrey B. Chief Executive Officer

P Jan 29, 2024

Boller Kenneth CFO

P Jan 29, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading AKTS

GADICKE ANSBERT

35 trades · score 74.0

Kim Helen Susan

8 trades · score 69.0

Foley Todd

7 trades · score 69.0

Frequently asked

How many insider trades does FilingIQ track for AKTS?: FilingIQ tracks 352 Form 4 insider transactions for AKTS (Aktis Oncology, Inc.), covering filings from Jul 10, 2017 onwards. 1 of those were filed in the last 90 days.
Are AKTS insiders net buyers or net sellers?: Across the full Form 4 history for AKTS, 25 transactions (7%) were open-market purchases and 181 (51%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AKTS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is AKTS in?: Aktis Oncology, Inc. (AKTS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $838.03M.

Methodology & sources

Every AKTS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.